To discuss the clinical and therapeutic implications of the study's findings on DNA-PKcs and INF2 in sepsis-induced cardiomyopathy (SIC), focus on how these discoveries could influence future treatment strategies. The gene discussed is PRKDC; the disease is cardiomyopathy.